Hormone replacement therapy (HRT) in post-menopausal women, particularly in women who have had hysterectomy. Relief of menopausal symptoms. Prevention of osteoporosis.
View Estrofem overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Known, suspected or history of breast cancer; known, suspected or history of oestrogen-sensitive cancer eg, endometrial cancer; unexpected vag bleeding; untreated endometrial hyperplasia; thrombosis eg, DVT or pulmonary embolism; blood clotting disorder eg, protein C, protein S or antithrombin deficiency; known or recent disease caused by arterial blood clots eg, heart attack, stroke or angina; liver disease & liver function tests have not returned to normal; porphyria.
Premature menopause. Use cautiously in patients w/ fibroids inside the womb; endometriosis or history of endometrial hyperplasia; increased risk of blood clots; increased risk of oestrogen-sensitive cancer; HTN; liver disorder eg, benign liver tumour; diabetes; gallstones; migraine or severe headaches; autoimmune disorders eg, SLE; epilepsy; asthma; otosclerosis; hypertriglyceridemia; fluid retention due to cardiac or kidney problems. Discontinue use in case of jaundice; HTN; migraine-like headaches occurring for the 1st time; pregnancy; signs of blood clots eg, painful swelliing & redness of legs, sudden chest pain & difficulty in breathing. Increased risk of memory loss in women >65 yr. May affect results of some laboratory tests. Lactose intolerance.
Manage Account
Change Password
Sign Out
